Poordad, F., Brau, N., Lawitz, E. J., Shiffman, M. L., McHutchison, J. G., Muir, A. J., … Sulkowski, M. S. (2008). HEMATOLOGIC SAFETY DATA FROM THE IDEAL TRIAL: NEUTROPENIA, ANEMIA AND THROMBOCYTOPENIA PROFILES OF PEGINTERFERON ALFA/RIBAVIRIN. In HEPATOLOGY (Vol. 48, pp. 1145A-1145A). San Francisco, CA: JOHN WILEY & SONS INC.

Poordad, Fred, Norbert Brau, Eric J. Lawitz, Mitchell L. Shiffman, John G. McHutchison, Andrew J. Muir, Greg Wayne Galler, et al. “HEMATOLOGIC SAFETY DATA FROM THE IDEAL TRIAL: NEUTROPENIA, ANEMIA AND THROMBOCYTOPENIA PROFILES OF PEGINTERFERON ALFA/RIBAVIRIN.” In HEPATOLOGY, 48:1145A-1145A. JOHN WILEY & SONS INC, 2008.

Poordad F, Brau N, Lawitz EJ, Shiffman ML, McHutchison JG, Muir AJ, et al. HEMATOLOGIC SAFETY DATA FROM THE IDEAL TRIAL: NEUTROPENIA, ANEMIA AND THROMBOCYTOPENIA PROFILES OF PEGINTERFERON ALFA/RIBAVIRIN. In: HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 1145A-1145A.

Poordad, Fred, et al. “HEMATOLOGIC SAFETY DATA FROM THE IDEAL TRIAL: NEUTROPENIA, ANEMIA AND THROMBOCYTOPENIA PROFILES OF PEGINTERFERON ALFA/RIBAVIRIN.” HEPATOLOGY, vol. 48, no. 4, JOHN WILEY & SONS INC, 2008, pp. 1145A-1145A.

Poordad F, Brau N, Lawitz EJ, Shiffman ML, McHutchison JG, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis M, Herrine SK, Gibas AL, Freilich B, King JW, Rossaro L, Mukhopadhyay P, Noviello S, Brass CA, Albrecht JK, Sulkowski MS. HEMATOLOGIC SAFETY DATA FROM THE IDEAL TRIAL: NEUTROPENIA, ANEMIA AND THROMBOCYTOPENIA PROFILES OF PEGINTERFERON ALFA/RIBAVIRIN. HEPATOLOGY. JOHN WILEY & SONS INC; 2008. p. 1145A-1145A.